Apigenin isolated from the medicinal plant Elsholtzia rugulosa prevents β-amyloid 25-35-induces toxicity in rat cerebral microvascular endothelial cells

Molecules

Volumn 16, Issue 5, 2011, Pages 4005-4019

  Zhao, Le ^a   Hou, Lin ^b   Sun, Huijun ^b   Yan, Xin ^b   Sun, Xifeng ^a   Li, Jianguang ^a   Bian, Yong ^a   Chu, Yu ^a   Liu, Qingshan ^c  

^a Beijing Entry Exit Inspection and Quarantine Bureau   (China)

^b JINAN CENTRAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

^c MINZU UNIVERSITY OF CHINA   (China)

Author keywords

Alzheimer's disease; Amyloid peptide; Apigenin; Elsholtzia rugulosa; Microvascular endothelial cells

Indexed keywords

EID: 79957594464     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules16054005     Document Type: Article

References (56)

1. Kalaria, R.N. The role of cerebral ischemia in Alzheimer's disease. Neurobiol. Aging 2000, 21, 321-330. (Pubitemid 30387091)
2. Han, B.H.; Zhou, M.L.; Abousaleh, F.; Brendza, R.P.; Dietrich, H.H.; Koenigsknecht-Talboo, J.; Cirrito, J.R.; Milner, E.; Holtzman, D.M.; Zipfel, G.J. Cerebrovascular dysfunction in amyloid precursor protein transgenic mice: Contribution of soluble and insoluble amyloid-beta peptide, partial restoration via gamma-secretase inhibition. J. Neurosci. 2008, 28, 13542-13550.
3. Yamada, M. Cerebral amyloid angiopathy: An overview. Neuropathology 2000, 20, 8-22. (Pubitemid 30312572)
4. Jellinger, K.A. Alzheimer disease and cerebrovascular pathology: An update. J. Neural. Transm. 2002, 109, 813-836. (Pubitemid 34810776)
5. Bell, R.D.; Zlokovic, B.V. Neurovascular mechanisms and bloodbrain barrier disorder in Alzheimer's disease. Acta Neuropathol. 2009, 118, 103-113.
6. Jellinger, K.A.; Attems, J. Prevalence and pathogenic role of cerebrovascular lesions in Alzheimer disease. J. Neurol. Sci. 2005, 229-230, 37-41.
7. Farkas, E.; Luiten, P.G. Cerebral microvascular pathology in aging and Alzheimer's disease. Prog. Neurobiol. 2001, 64, 575-611. (Pubitemid 32304447)
8. Wisniewski, H.M; Vorbrodt, A.W.; Wegiel, J. Amyloid angiopathy and blood-brain barrier changes in Alzheimer's disease. Ann. NY Acad. Sci. 1997, 826, 161-172. (Pubitemid 27478038)
9. Suo, Z.; Tan, J.; Placzek, A.; Crawford, F.; Fang, C.; Mullan, M. Alzheimer's beta-amyloid peptides induce inflammatory cascade in human vascular cells: The roles of cytokines and CD40. Brain Res. 1998, 80, 110-117. (Pubitemid 29005242)
10. Giri, R.; Shen, Y.; Stins, M.; Du Yan, S.; Schmidt, A.M.; Stern, D.; Kim, K.S; Zlokovic, B.; Kalra, V.K. beta-amyloid-induced migration of monocytes across human brain endothelial cells involves RAGE and PECAM-1 Am. J. Physiol. Cell Physiol. 2000, 279, C1772-C1781.
11. Blanc, E.M.; Toborek, M.; Mark, R.J.; Hennig, B.; Mattson, M.P. Amyloid beta-peptide induces cell monolayer albumin permeability, impairs glucose transport, and induces apoptosis in vascular endothelial cells. J. Neurochem. 1997, 68, 1870-1881. (Pubitemid 27176122)
12. Strazielle, N.; Ghersi-Egea, J.F.; Ghiso, J.; Dehouck, M.P.; Frangione, B.; Patlak, C.; Fenstermacher, J.; Gorevic, P. In vitro evidence that beta-amyloid peptide 1-40 diffuses across the blood-brain barrier and affects its permeability. J. Neuropathol. Exp. Neurol. 2000, 59, 29-38. (Pubitemid 30069223)
13. Liu, R.; Lan, X.; Ying, J.; Du, G.H. Protective effects of luteolin against amyloid β25-35-induced toxicity on rat cerebral microvascular endothelial cells. Chin. J. Nat. Med. 2010, 8, 223-227.
14. Zlokovic, B.V. The blood-brain barrier in health and chronic neurodegenerative disorders. Neuron 2008, 57, 178-201.
15. Jaeger, L.B.; Dohgu, S.; Hwang, M.C.; Farr, S.A.; Murphy, M.P.; Fleegal Demotta, M.A.; Lynch, J.A.; Robinson, S.M.; Niehoff, M.L.; Johnson, S.N.; et al. Testing the neurovascular hypothesis of Alzheimer's disease: LRP1 antisense reduces blood brain barrier clearance and increases brain levels of amyloid-β protein and impairs cognition. J. Alzheimers Dis. 2009, 17, 553-570.
16. Wu, C.Y. Flora of China; Science Press: Beijing, China, 1988; Volume 66, p. 308.
17. Jiangshu New College of Medicine. The Dictionary of Chinese Medicine; Shanghai Press of Science and Technology: Shanghai, China, 1985; p. 2132.
18. McVean, M.; Weinberg, W.C.; Pelling, J.C. A p21(waf1)-independent pathway for inhibitory phosphorylation of cyclin-dependent kinase p34(cdc2) and concomitant G(2)/M arrest by the chemopreventive flavonoid apigenin. Mol. Carcinog. 2002, 33, 36-43. (Pubitemid 34052305)
19. Wang, I.K.; Lin-Shiau, S.Y.; Lin, J.K. Induction of apoptosis by apigenin and related flavonoids through cytochrome c release and activation of caspase-9 and caspase-3 in leukaemia HL-60 cells. Eur. J. Cancer 1999, 35, 1517-1525.
20. Vargo, M.A.; Voss, O.H.; Poustka, F.; Cardounel, A.J.; Grotewold, E.; Doseff, A.I. Apigenin-induced-apoptosis is mediated by the activation of PKCd and caspases in leukemia cells. Biochem. Pharmacol. 2006, 72, 681-692. (Pubitemid 44233544)
21. Fotsis, T.; Pepper, M.S.; Aktas, E.; Breit, S.; Rasku, S.; Adlercreutz, H.; Wähälä, K.; Montesano, R.; Schweigerer, L. Flavonoids, dietary-derived inhibitors of cell proliferation and in vitro angiogenesis. Cancer Res. 1997, 57, 2916-2921. (Pubitemid 27315039)
22. Yin, F.; Giuliano, A.E.; Law, R.E.; Van Herle, A.J. Apigenin inhibits growth and induces G2/M arrest by modulating cyclin-CDK regulators and ERK MAP kinase activation in breast carcinoma cells. Anticancer Res. 2001, 21, 413-420. (Pubitemid 32267675)
23. Chen, D.; Daniel, K.G.; Chen, M.S.; Kuhn, D.J.; Landis-Piwowar, K.R.; Dou, Q.P. Dietary flavonoids as proteasome inhibitors and apoptosis inducers in human leukemia cells. Biochem. Pharmacol. 2005, 69, 1421-1432. (Pubitemid 40602442)
24. Woodman, O.L.; Chan, E. Vascular and anti-oxidant actions of flavonols and flavones. Clin. Exp. Pharmacol. Physiol. 2004, 31, 786-790. (Pubitemid 39556854)
25. Olszanecki, R.; Gebska, A.; Kozlovski, V.I.; Gryglewski, R.J. Flavonoids and nitric oxide synthase. J. Physiol. Pharmacol. 2002, 53, 571-584. (Pubitemid 36014803)
26. Zhang, Y.H.; Park, Y.S.; Kim, T.J.; Fang, L.H.; Ahn, H.Y.; Hong, J.T.; Kim, Y.; Lee, C.K.; Yun, Y.P. Endothelium-dependent vasorelaxant and antiproliferative effects of apigenin. Gen. Pharmacol. 2000, 35, 341-347. (Pubitemid 34258517)
27. Guerrero, J.A.; Lozano, M.L.; Castillo, J.; Benavente-Garcia, O.; Vicente, V.; Rivera, J. Flavonoids inhibit platelet function through binding to the thromboxane A2 receptor. J. Thromb. Haemost. 2005, 3, 369-376. (Pubitemid 41623628)
28. Abbott, N.J.; Ronnback, L.; Hansson, E. Astrocyte-endothelial interactions at the blood-brain barrier. Nat. Rev. Neurosci. 2006, 7, 41-53. (Pubitemid 41828930)
29. Preston, J.E.; Hipkiss, A.R.; Himsworth, D.T.; Romero, I.A.; Abbott, N.J. Toxic effects of β-amyloid(25-35) on immortalized rat brain endothelial cell: Protection by carnosine, homocarnosine and β-alanine. Neurosci. Lett. 1998, 242, 105-108. (Pubitemid 28083003)
30. Folin, M.; Baiguera, S.; Tommasini, M.; Guidolin, D.; Conconi M.T.; DeCarlo, E.; Nussdorfer, G.G.; Parnigotto, P.P. Effects of β-amyloid on rat neuromicrovascular endothelial cells cultured in vitro. Int. J. Mol. Med. 2005, 15, 929-935.
31. Shukla, A.; Shukla, R.; Dikshit, M.; Srimal, R.C. Alterations in free radical scavenging mechanisms following blood-brain barrier disruption. Free Radic. Biol. Med. 1993, 15, 97-100. (Pubitemid 23171446)
32. Zlokovic, B.V. Neurovascular mechanisms of Alzheimer's neurodegeneration. Trends Neurosci. 2005, 28, 202-208 (Pubitemid 40445527)
33. Kneisel, U.; Wolburg, H. Tight junctions of the blood-brain barrier. Cell. Mol. Neurobiol. 2000, 20, 57-76. (Pubitemid 30090916)
34. Butt, A.M.; Jones, H.C.; Abbott, N.J. Electrical resistance across the blood-brain barrier in anaesthetized rats: A developmental study. J. Physiol. 1990, 429, 47-62. (Pubitemid 20327537)
35. Harhaj, N.S.; Antonetti, D.A. Regulation of tight junctions and loss of barrier function in pathophysiology. Int. J. Biochem. Cell Biol. 2004, 36, 1206-1237. (Pubitemid 38519069)
36. Deli, M.A.; Abraham, C.S.; Kataoka, Y.; Niwa, M. Permeability studies on in vitro blood-brain barrier models: Physiology, pathology, and pharmacology. Cell. Mol. Neurobiol. 2005, 25, 59-127. (Pubitemid 40558585)
37. Gumbleton, M.; Audus, K.L. Progress and limitations in the use of in vitro cell cultures to serve as a permeability screen for the blood-brain barrier. J. Pharm. Sci. 2001, 90, 1681-1698. (Pubitemid 33062590)
38. Lawrenson, J.G.; Reid, A.R.; Finn, T.M.; Orte, C.; Allt, G. Cerebral and pial microvessels: Differential expression of gamma-glutamyl transpeptidase and alkaline phosphatase. Anat. Embryol. (Berl) 1999, 199, 29-34. (Pubitemid 29132451)
39. Meyer, J.; Mischeck, U.; Veyhl, M.; Henzel, K.; Galla, H.J. Blood-brain barrier characteristic enzymatic properties in cultured brain capillary endothelial cells. Brain Res. 1990, 514, 305-309. (Pubitemid 20151381)
40. Frey, A.; Meckelein, B.; Weiler-Guttler, H.; Mockel, B.; Flach, R.; Gassen, H.G. Pericytes of the brain microvasculature express gamma-glutamyl transpeptidase. Eur. J. Biochem. 1991, 202, 421-429.
41. Roux, F.; Durieu-Trautmann, O.; Chaverot, N.; Claire, M.; Mailly, P.; Bourre, J.M.; Strosberg, A.D.; Couraud, P.O. Regulation of gamma-glutamyl transpeptidase and alkaline phosphatase activities in immortalized rat brain microvessel endothelial cells. J. Cell. Physiol. 1994, 159, 101-113. (Pubitemid 24234582)
42. Wolf, S.; Gassen, H.G. Gamma-glutamyl transpeptidase, a blood-brain barrier associated membrane protein. Splitting peptides to transport amino acids. Adv. Exp. Med. Biol. 1997, 421, 37-45. (Pubitemid 27432651)
43. Singh, J.; Chander, J.; Singh, S.; Singh, G.; Atal, C.K. Gamma-glutamyl transpeptidase: A novel biochemical marker in inflammation. Biochem. Pharmacol. 1986, 35, 3753-3760. (Pubitemid 17180424)
44. Kugelman, A.; Choy, H.A.; Liu, R.; Shi, M.M.; Gozal, E.; Forman, H.J. gamma-Glutamyl transpeptidase is increased by oxidative stress in rat alveolar L2 epithelial cells. Am. J. Respir. Cell Mol. Biol. 1994, 11, 586-592.
45. Yu, C.; Kastin, A.J.; Ding, Y.; Pan, W. Gamma glutamyl transpeptidase is a dynamic indicator of endothelial response to stroke. Exp. Neurol. 2007, 203, 116-122. (Pubitemid 44821169)
46. Plateel, M.; Dehouck, M.P.; Torpier, G.; Cecchelli, R.; Teissier, E. Hypoxia increases the susceptibility to oxidant stress and the permeability of the blood-brain barrier endothelial cell monolayer. J. Neurochem. 1995, 65, 2138-2145.
47. Han, J.; Shuvaev, V.V.; Muzykantov, V.R. Catalase and SOD conjugated with PECAM antibody distinctly alleviate abnormal endothelial permeability caused by exogenous ROS and vascular endothelial growth factor. J. Pharmacol. Exp. Ther. 2011, Epub ahead of print.
48. Boueiz, A.; Hassoun, P.M. Regulation of endothelial barrier function by reactive oxygen and nitrogen species. Microvasc. Res. 2009, 77, 26-34.
49. Liu, R.; Zhang, T.; Yang, H.; Lan, X.; Ying, J.; Du, G. The flavonoid apigenin protects brain neurovascular coupling against amyloid-β25-35- induced toxicity in mice. J. Alzheimers Dis. 2011, 4, 85-100.
50. Stamatovic, S.M.; Dimitrijevic, O.B.; Keep, R.F.; Andjelkovic, A.V. Protein kinase Calpha-RhoA cross-talk in CCL2-induced alterations in brain endothelial permeability. J. Biol. Chem. 2006, 281, 8379-8388. (Pubitemid 43847939)
51. Ishizaki, T.; Chiba, H.; Kojima, T.; Fujibe, M.; Soma, T.; Miyajima, H.; Nagasawa, K.; Wada, I.; Sawada, N. Cyclic AMP induces phosphorylation of claudin-5 immunoprecipitates and expression of claudin-5 gene in blood-brain-barrier endothelial cells via protein kinase A-dependent and -independent pathways. Exp. Cell. Res. 2003, 290, 275-288. (Pubitemid 37272172)
52. Duarte, J.; Pérez Vizcaíno, F.; Utrilla, P.; Jiménez, J.; Tamargo, J.; Zarzuelo, A. Vasodilatory effects of flavonoids in rat aortic smooth muscle. Structure-activity relationships. Gen. Pharmacol. 1993, 24, 857-862. (Pubitemid 23231766)
53. He, C.; Xiao, W.; Li, M.; Peng, Y.; Xu, L.; Gu, J.; Xiao, P. Chemical constituents from seeds of Paeonia suffruticosa. Zhongguo Zhong Yao Za Zhi 2010, 35, 1428-1431.
54. Liu, R.; Zhang, L.; Lan, X.; Li, L.; Zhang, T.T.; Sun, J.H.; Du, G.H. Protection by borneol on cortical neurons against oxygen-glucose deprivation/reperfusion: Involvement of anti-oxidation and anti-inflammation through nuclear transcription factor kappaB signaling pathway. Neuroscience 2011, 176, 408-419.
55. Liu, R.; Gao, M.; Yang, Z.H.; Du, G.H. Pinocembrin protects rat brain against oxidation and apoptosis induced by ischemia-reperfusion both in vivo and in vitro. Brain Res. 2008, 1216, 104-115.
56. Veszelka, S.; Pasztoi, M.; Farkas, A.E.; Krizbai, I.; Dung, N.T.K.; Niwa, M.; Abraham, C.S.; Deli, M.A. Pentosan polysulfate protects brain endothelial cells against bacterial lipopolysaccharideinduced damages. Neurochem. Int. 2007, 50, 219-228. (Pubitemid 44879678)